Delivery Order SPE2DP20D0002-SPE2DP22F3547
Award Date 3/22/22
Potential Completion Date 3/29/22
Potential Value $294K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency Troop Support Medical awarded a $293,647.86 firm fixed price delivery order contract to Teva Pharmaceuticals USA, Inc. of Parsippany, New Jersey. The contract is to provide adenovirus type 4 from April 19, 2022 through April 26, 2022. Teva Pharmaceuticals USA, Inc. will perform as the prime contractor to supply this pharmaceutical to the Defense Logistics Agency Troop Support Medical. No applicable subcontractors were identified.</p>
- The Defense Logistics Agency Troop Support Medical awarded a $152,696.88 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc. of Parsippany, New Jersey. Under this contract, Teva will provide adenovirus type 4 to the agency. The contract has a period of performance from March 22, 2023 through March 28, 2023 for delivery of the requested pharmaceutical products. No additional details were provided regarding major subcontractors or set aside designations. Teva will fulfill the order...
- The Defense Logistics Agency Troop Support Medical awarded a $564,707 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc. for adenovirus type 4. The place of performance is Teva's facility in Parsippany, New Jersey. The contract period runs from January 14, 2021 through January 26, 2021. Teva will deliver the requested adenovirus type 4 to support the Defense Logistics Agency's medical supply chain needs. As the Defense Logistics Agency is responsible for worldwide logistics...
- The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $293,647.86 firm fixed price delivery order contract to provide Adenovirus Type 4. The place of performance for this contract is Parsippany, New Jersey, and the period of performance is from September 13, 2022 through September 20, 2022. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor to supply this pharmaceutical product to the Defense Logistics Agency Troop Support Medical. No...
- The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $293,647.86 firm fixed price delivery order contract to provide Adenovirus Type 4. The place of performance for this contract is Parsippany, New Jersey, and the period of performance is from April 19, 2022 through April 26, 2022. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor to supply this pharmaceutical product to the Defense Logistics Agency Troop Support Medical. No applicable...
- The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $423,530.64 firm fixed price delivery order contract to provide Adenovirus Type 4. The place of performance for this contract is Parsippany, New Jersey, and the period of performance is from December 7, 2021 through December 14, 2021. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor to supply this pharmaceutical product to the Defense Logistics Agency Troop Support Medical. No...
- <p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $1,027,767.51 firm fixed price delivery order contract to provide Adenovirus Type 4 from its Parsippany, New Jersey facility. Teva Pharmaceuticals USA, Inc. will deliver the Adenovirus Type 4 between December 6, 2022 and December 20, 2022 to support the Defense Logistics Agency Troop Support Medical's medical requirements.</p>
- The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $293,647.86 firm fixed price delivery order contract to provide Adenovirus Type 4. The place of performance for this contract is Parsippany, New Jersey, and the period of performance is from August 18, 2022 through August 30, 2022. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor to supply this pharmaceutical product to the Defense Logistics Agency Troop Support Medical. No applicable...
- <p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $293,647.86 firm fixed price delivery order contract to provide adenovirus type 4 from its Parsippany, New Jersey facility. The contract has a period of performance starting on May 17, 2022 and ending on May 24, 2022. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor to supply adenovirus type 4 to the Defense Logistics Agency Troop Support Medical.</p>
- The Defense Logistics Agency Troop Support Medical awarded a $564,707 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc. of Parsippany, New Jersey. Under the contract, Teva will provide adenovirus type 4 to the agency by September 28, 2021 from its facility in New Jersey. The Defense Logistics Agency supports Department of Defense health care programs by procuring pharmaceuticals, medical supplies, and equipment to maintain military readiness. No set aside designation or...
- SPE2DP20D0002Indefinite Delivery Contract
- SPE2DP20D0002-SPE2DP22F3547Delivery Order
The Defense Logistics Agency Troop Support Medical awarded a $293,647.86 firm fixed price delivery order contract to Teva Pharmaceuticals USA, Inc. of Parsippany, New Jersey. The contract is to provide adenovirus type 4 to the Defense Logistics Agency from March 22, 2022 through March 29, 2022. Teva Pharmaceuticals USA, Inc. will perform all work as the prime contractor, with no indication of the use of subcontractors on this contract.
Generated 11/27/23, 8:11 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $293.6k | 3/22/22 |